Verano Holdings (VRNO) Cash & Current Investments (2021 - 2026)

Verano Holdings' (VRNO) quarterly Cash & Current Investments came in at $74.0 million in Q1 2026, down 12.1% year-on-year from $84.2 million in Q1 2025, and down 10.51% on a QoQ basis from $82.7 million in Q4 2025.

Verano Holdings (VRNO) Cash & Current Investments (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has 6 years of Cash & Current Investments data on file, last reported at $74.0 million in Q1 2026.

  • On a quarterly basis, Cash & Current Investments fell 12.1% year-over-year to $74.0 million in Q1 2026; TTM through Mar 2026 was $74.0 million, a 12.1% decrease from a year earlier, with the FY2025 full-year figure at $82.7 million, down 5.78% from the prior year.
  • Cash & Current Investments for Q1 2026 stood at $74.0 million, down from $82.7 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for VRNO reached as high as $193.8 million in Q1 2024 and fell as low as $65.0 million in Q3 2024.
  • Historically, Cash & Current Investments has averaged $101.6 million across 5 years, with a median of $86.3 million in 2022.
  • Across the five-year window, Cash & Current Investments jumped 105.96% in 2023 and slumped 56.54% in 2025, its largest moves.
  • Year by year, Cash & Current Investments stood at $84.9 million in 2022, then soared by 105.96% to $174.8 million in 2023, then plunged by 49.76% to $87.8 million in 2024, then fell by 5.78% to $82.7 million in 2025, then slipped by 10.51% to $74.0 million in 2026.
  • Per Business Quant data, the three most recent Cash & Current Investments figures were $74.0 million in Q1 2026, $82.7 million in Q4 2025, and $82.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Haleon 91.93 Bn 90.07 Bn - 1.86 Bn
2 Teva Pharmaceutical Industries 36.31 Bn 32.57 Bn 1.97 Bn 3.74 Bn
3 Zoetis 33.01 Bn 31.07 Bn 1.62 Bn 1.94 Bn
4 Takeda Pharmaceutical 27.65 Bn 23.59 Bn 4.39 Bn 4.06 Bn
5 United Therapeutics 22.96 Bn 20.81 Bn 648.10 Mn 2.15 Bn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.50 Bn 18.69 Bn 1.16 Bn 1.80 Bn
8 Neurocrine Biosciences 18.16 Bn 16.85 Bn 800.70 Mn 1.32 Bn
9 Elanco Animal Health 12.84 Bn 12.41 Bn 785.00 Mn 428.00 Mn
10 Verano Holdings 1.90 Bn 1.83 Bn 98.98 Mn 74.03 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 74.03 Mn
Dec 31, 2025 82.72 Mn
Sep 30, 2025 82.62 Mn
Jun 30, 2025 68.57 Mn
Mar 31, 2025 84.22 Mn
Dec 31, 2024 87.80 Mn
Sep 30, 2024 64.98 Mn
Jun 30, 2024 130.05 Mn
Mar 31, 2024 193.80 Mn
Dec 31, 2023 174.76 Mn
Sep 30, 2023 129.92 Mn
Jun 30, 2023 102.58 Mn
Mar 31, 2023 95.13 Mn
Dec 31, 2022 84.85 Mn
Sep 30, 2022 76.42 Mn
Jun 30, 2022 92.83 Mn
Dec 31, 2021 99.12 Mn